PL2528896T3 - Syntetyczny związek pośredni dla związku oksazolu i sposób jego wytwarzania - Google Patents

Syntetyczny związek pośredni dla związku oksazolu i sposób jego wytwarzania

Info

Publication number
PL2528896T3
PL2528896T3 PL11706939T PL11706939T PL2528896T3 PL 2528896 T3 PL2528896 T3 PL 2528896T3 PL 11706939 T PL11706939 T PL 11706939T PL 11706939 T PL11706939 T PL 11706939T PL 2528896 T3 PL2528896 T3 PL 2528896T3
Authority
PL
Poland
Prior art keywords
producing
same
synthetic intermediate
oxazole compound
oxazole
Prior art date
Application number
PL11706939T
Other languages
English (en)
Inventor
Akihiro Yamamoto
Koichi Shinhama
Nobuhisa Fujita
Shinji Aki
Shin Ogasawara
Naoto Utsumi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PL2528896T3 publication Critical patent/PL2528896T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL11706939T 2010-01-29 2011-01-28 Syntetyczny związek pośredni dla związku oksazolu i sposób jego wytwarzania PL2528896T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010019289 2010-01-29
EP11706939.3A EP2528896B1 (en) 2010-01-29 2011-01-28 Synthetic intermediate of oxazole compound and method for producing the same
PCT/JP2011/052307 WO2011093529A1 (en) 2010-01-29 2011-01-28 Synthetic intermediate of oxazole compound and method for producing the same

Publications (1)

Publication Number Publication Date
PL2528896T3 true PL2528896T3 (pl) 2015-01-30

Family

ID=43759747

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11706939T PL2528896T3 (pl) 2010-01-29 2011-01-28 Syntetyczny związek pośredni dla związku oksazolu i sposób jego wytwarzania

Country Status (28)

Country Link
US (1) US8598358B2 (pl)
EP (1) EP2528896B1 (pl)
JP (1) JP5818802B2 (pl)
KR (1) KR101839160B1 (pl)
CN (1) CN102725269B (pl)
AR (1) AR080287A1 (pl)
AU (1) AU2011211311A1 (pl)
BR (1) BR112012018069A2 (pl)
CA (1) CA2787246A1 (pl)
CY (1) CY1115654T1 (pl)
DK (1) DK2528896T3 (pl)
EA (1) EA201290681A1 (pl)
EG (1) EG26595A (pl)
ES (1) ES2509946T3 (pl)
HK (1) HK1174031A1 (pl)
HR (1) HRP20141087T1 (pl)
IL (1) IL220754A (pl)
MX (1) MX2012008501A (pl)
MY (1) MY156360A (pl)
NZ (1) NZ601239A (pl)
PL (1) PL2528896T3 (pl)
PT (1) PT2528896E (pl)
SG (1) SG181990A1 (pl)
SI (1) SI2528896T1 (pl)
TW (1) TW201200523A (pl)
UA (1) UA108092C2 (pl)
WO (1) WO2011093529A1 (pl)
ZA (1) ZA201204802B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201632533A (zh) 2015-01-29 2016-09-16 南京明德新藥研發股份有限公司 抗肺結核病的硝基咪唑衍生物
JP6776226B2 (ja) * 2015-03-27 2020-10-28 大塚製薬株式会社 1−(4−ヒドロキシフェニル)−4−(4−トリフルオロメトキシフェノキシ)ピペリジン又はその塩の製造方法
WO2020202205A1 (en) * 2019-04-01 2020-10-08 Council Of Scientific And Industrial Research Process for the preparation of derivatives of 1,1-dialkylethane-1,2-diols as useful intermediates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2871063B2 (ja) 1990-10-26 1999-03-17 日本たばこ産業株式会社 (r,z)―5―テトラデセン―4―オリドの製造方法
TWI347946B (en) * 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
TWI331607B (en) 2002-10-15 2010-10-11 Otsuka Pharma Co Ltd 1-substituted-4-nitroimidazole compound
UA88925C2 (en) * 2002-10-15 2009-12-10 Оцука Фармасьютикал Ко., Лтд. 4-nitroimidazole derivatives
DK1906926T3 (da) * 2005-07-28 2011-01-31 Otsuka Pharma Co Ltd Farmaceutisk sammensætning omfattende 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolderivater
JP5105818B2 (ja) * 2005-10-05 2012-12-26 大塚製薬株式会社 医薬組成物
AR070301A1 (es) 2007-05-08 2010-03-31 Otsuka Pharma Co Ltd Compuesto epoxi y metodo para producir el mismo
JP2009269859A (ja) * 2008-05-08 2009-11-19 Otsuka Pharmaceut Co Ltd N−含有複素環化合物
EP2323990B1 (en) * 2008-08-21 2014-06-18 Dynamit Nobel GmbH Explosivstoff- und Systemtechnik Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof

Also Published As

Publication number Publication date
AR080287A1 (es) 2012-03-28
CN102725269A (zh) 2012-10-10
MX2012008501A (es) 2012-08-17
HRP20141087T1 (hr) 2015-01-16
UA108092C2 (ru) 2015-03-25
KR101839160B1 (ko) 2018-03-15
EA201290681A1 (ru) 2013-02-28
HK1174031A1 (en) 2013-05-31
KR20120130326A (ko) 2012-11-30
TW201200523A (en) 2012-01-01
NZ601239A (en) 2014-10-31
SI2528896T1 (sl) 2014-12-31
EP2528896A1 (en) 2012-12-05
SG181990A1 (en) 2012-08-30
WO2011093529A1 (en) 2011-08-04
MY156360A (en) 2016-02-15
JP2013518033A (ja) 2013-05-20
ES2509946T3 (es) 2014-10-20
EG26595A (en) 2014-03-20
IL220754A (en) 2015-10-29
PT2528896E (pt) 2014-10-09
US8598358B2 (en) 2013-12-03
EP2528896B1 (en) 2014-08-27
DK2528896T3 (da) 2014-11-10
JP5818802B2 (ja) 2015-11-18
CN102725269B (zh) 2015-03-25
US20120302757A1 (en) 2012-11-29
AU2011211311A1 (en) 2012-07-26
ZA201204802B (en) 2013-09-25
BR112012018069A2 (pt) 2016-02-23
CY1115654T1 (el) 2017-01-25
CA2787246A1 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
IL248217B (en) A method for the production of inganol-3-englate
IL228845A0 (en) Antimicrobial compounds and methods for their preparation and use
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
HK1184440A1 (en) Synthetic process for the manufacture of ecteinascidin compounds and intermediates
EP2539444A4 (en) COMPOSITIONS AND METHODS FOR THE PRODUCTION OF L-HOMOALANINE
EP2739657A4 (en) CYCLOOLEFIN POLYMER COMPOUND AND PROCESS FOR PREPARING THE SAME
EP2657223A4 (en) METAL-SALEN COMPLEX COMPOUND AND PROCESS FOR PRODUCING THE SAME
SG11201400405TA (en) Caninised antibodies and method for the production of same
HK1189236A1 (en) Macrocyclic compound and methods for its production
SG11201400909WA (en) Composition and method for producing same
GB201207599D0 (en) Transistor and the method of manufacture
IL222184A (en) Amino-pyridine-n- oxides are converted and methods of preparation
GB2495884B (en) A method of increasing the effect of an activated-potentiated form of an antibody
AP2013006897A0 (en) Method for the manufacturing of naltrexone
EP2647623A4 (en) METHOD FOR PRODUCING AN ISOTHIOCYANATE COMPOUND
HK1174031A1 (en) Synthetic intermediate of oxazole compound and method for producing the same
EP2543658A4 (en) PROCESS FOR PRODUCING A-ACYLOXYCARBONYL COMPOUND AND NO-ACYLOXYCARBONYL COMPOUND
HUE036407T2 (hu) Difenilamin vegyület és eljárás elõállítására
EP2752416A4 (en) NOVEL MANGROMICIN COMPOUND AND PROCESS FOR PRODUCING THE SAME
GB201020357D0 (en) Compounds and methods of making the same
EP2772544A4 (en) NEW CONNECTION AND METHOD FOR THE PRODUCTION THEREOF
PL2487372T3 (pl) Zespół mocujący i sposób jego wytwarzania
GB201021522D0 (en) Novel compounds and methods for their production
GB201120685D0 (en) Drill and method of making the same